FDA Good Move! 50K cap on advisory hearings

Wednesday, August 6, 2008

Updated July 26, 2016

You might also be interested in this FDA draft guidance:

06/2016 Procedures for Evaluating Appearance Issues and Granting Authorizations for Participation in FDA Advisory Committees (PDF - 947KB)

- - original post follows below - -

I like this. This is a good step by the FDA to reduce conflicts of interest by its committees of expert advisers. For complete details, read this FDA news release, "FDA Announces Improved Policies Regarding Transparency, Public Disclosure for Advisory Committees. "

Here's what I like about the changes. The FDA says that the expert advisers will be, "screened by FDA staff to determine whether they have a potential financial conflict of interest, such as grants, stock holdings and contracts with a company that would be affected by the committee’s recommendations. Today, FDA is instituting a cap of $50,000 as the maximum personal financial interest an advisor may have in all companies that may be affected by a particular meeting." If this works as intended, the recommendations coming from Advisory Committees can be expected to be above board, and hopefully completely objective. We can only hope.

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

If you are looking for live, onsite, in-person delivered courses or classes, then consider the following popular courses: